- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objectives are to demonstrate the superiority of treatment with zoledronic acid Calcium and Vitamin D relative to placebo Calcium and Vitamin D regarding the percent change of BMD at lumbar spine and/or total hip at Month 12 relative to baseline as measured by DXA.
Inclusion criteria
- Osteoporosis